Dima El-Sharkawi

24PUBLICATIONS
151CO-AUTHORS
Molecular targetsAutoimmunityTumour immunologyHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Sep 18, 2026
A phase IIa study of the anti-PD-L1 antibody avelumab in relapsed/refractory PTCL: The AVAIL-T trial.

|Aug 25, 2026
International Consensus Criteria for the Diagnosis, Treatment Initiation, and Response Assessment for T-LGL Leukemia.

|Aug 23, 2026
The diagnosis and management of primary mediastinal B-cell lymphoma: A British Society for Haematology guideline.

|Apr 14, 2026
Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.

Clive S Zent, Enrico Tiacci, Robert J Kreitman

|Feb 05, 2026
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter transformation.

Katharine Louise Lewis, Sarit E Assouline, Ross Ian Baker

|Jan 06, 2026
Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma.

Juan Pablo Alderuccio, Diva Baggio, Sunwoo Han

Pageof 4

Frequent Collaborators

5 joint publications

Sunil Iyengar

4 joint publications

Christopher P Fox

3 joint publications

Andrew J Davies

2 joint publications

Matthew J Ahearne